Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01762722 · ClinicalTrials.gov registry record · NA
Nonin 4 Wavelength Cerebral Oximeter Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT01762722 is a NA study that has completed, run by Duke University. The registered enrollment target is 23 participants.
The verdict
NCT01762722, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
A cerebral oximeter is a device that uses light to measure the amount of oxygen within the brain. It is similar to the device that measures the level of oxygen in the tip of the finger, known as a pulse oximeter. The cerebral oximeter consists of a sensor placed on the forehead that both emits and detects the amount of light absorbed. This study will determine how accurate the device is by comparing the displayed value on the monitor with blood samples taken simultaneously from the arterial blood in the wrist and venous blood in the neck. In order to test the device over a suitable range, the level of oxygen within the blood will be reduced in a controlled manner by reduction of the inspired oxygen concentration. This is the equivalent of ascending to an altitude of 16,000 feet. The study will be conducted in healthy volunteers.
Interventions
- DEVICE Reduction of inspired oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01762722
The ClinicalTrials.gov registry entry for NCT01762722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reduction of inspired oxygen is the first listed.
NCT01762722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01762722 about?
NCT01762722 is a clinical study titled "Nonin 4 Wavelength Cerebral Oximeter Study". A cerebral oximeter is a device that uses light to measure the amount of oxygen within the brain. It is similar to the device that measures the level of oxygen in the tip of the finger, known as a pulse oximeter. The cerebral oximeter consists of a sensor placed on the forehead that both emits and d...
What is the current status of trial NCT01762722?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2009-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01762722?
The interventions under investigation include: Reduction of inspired oxygen (DEVICE).
Who is sponsoring clinical trial NCT01762722?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.